EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Resistance to CAR-based cell therapy: Mechanisms and overcoming strategies

Sha Sha, Xiaoyan Pang, Ning Wang, Yan Wang, Chi Zhang, Zihui Guo, Zhenfang Du, Lu Li, Ningning Liu, Le Qu

Drug Resistance Updates · 2026-11 · 89 · 101452

DOI: 10.1016/j.drup.2026.101452 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2026-11. Verfasst von Sha Sha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Hospital of China Medical University, Shenyang 110001, China. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Immunotherapy, Adoptive, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 335 Literaturangaben. Gefördert von: Liaoning Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR)-based cell therapy holds great promise for the treatment of both hematological malignancies and solid tumors. However, primary and acquired resistance to CAR-based cell therapy remains a key obstacle to achieving effective and durable immunotherapy responses. Unlike small molecules or antibodies, CAR-engineered immune cells offer unique opportunities to design therapeutic agents, thereby enabling the improved products with potential to overcome multiple therapy resistance mechanisms. Therefore, elucidating the mechanisms of resistance to CAR-based cell therapy is crucial for the development of the next-generation CAR-based cell therapy. In this review, we outline the biological rationale of CAR-T, CAR-natural killer (NK), and CAR-macrophages, as well as other emerging CAR-based cell therapies. We focus on the mechanisms of resistance to CAR-based cell therapy, involving structural and functional defects of CAR products, tumor-intrinsic factors, and susceptibility of CAR-engineered cells to the hostile tumor microenvironment. We discuss key strategies to overcome multiple resistance mechanisms, such as targeting multiple antigens, optimizing CAR design and function, modifying the immunosuppressive tumor microenvironment, and developing combination treatment strategies. By systematically dissecting these multifaceted challenges, this review will provide insights for optimizing CAR-based cell therapy to overcome resistance and improve treatment efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenImmunotherapy, AdoptiveNeoplasmsHumansTumor MicroenvironmentKiller Cells, NaturalAnimals

Stichwörter der Autor:innen

CAR-NK cellsCAR-T cellsCAR-macrophagesChimeric antigen receptorResistance

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Geriatrics, The First Hospital of China Medical University, Shenyang 110001, China.
  • Department of Gynecology, The First Hospital of China Medical University, Shenyang 110001, China.
  • Department of Cardiology, The First Hospital of China Medical University, Shenyang 110001, China.
  • Department of Pediatrics, Division of Pediatric Hematology/Oncology and Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI 48109, United States.
  • Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang 110004, China. Electronic address: benxn5088@163.com.
  • Department of Ophthalmology, The First Hospital of China Medical University, Shenyang 110001, China. Electronic address: ningning1688@126.com.

Förderung

  • Liaoning Provincial Natural Science Foundation

Zitieren

APA

Sha, S., Pang, X., Wang, N., Wang, Y., Zhang, C., Guo, Z., Du, Z., Li, L., Liu, N., & Qu, L. (2026). Resistance to CAR-based cell therapy: Mechanisms and overcoming strategies. Drug Resistance Updates, 89, 101452. https://doi.org/10.1016/j.drup.2026.101452

Vancouver

Sha S, Pang X, Wang N, Wang Y, Zhang C, Guo Z, et al. Resistance to CAR-based cell therapy: Mechanisms and overcoming strategies. Drug Resistance Updates. 2026;89:101452. doi:10.1016/j.drup.2026.101452

BibTeX
@article{Sha2026,
  author = {Sha, Sha and Pang, Xiaoyan and Wang, Ning and Wang, Yan and Zhang, Chi and Guo, Zihui and Du, Zhenfang and Li, Lu and Liu, Ningning and Qu, Le},
  title = {Resistance to CAR-based cell therapy: Mechanisms and overcoming strategies},
  journal = {Drug Resistance Updates},
  year = {2026},
  volume = {89},
  pages = {101452},
  doi = {10.1016/j.drup.2026.101452}
}
Kostenlos starten →